Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce the font size Increase the font size  
 
 
Committed to India's health since 1956
 
A global, integrated healthcare Leader
 
Your well-being, Our priority
 
Our key therapeutic areas: Cardiovascular Diseases, Thrombosis, Diabetes, Internal Medicine, Central Nervous System, Oncology, Arthritis and Osteoporosis, Primary Health Care, Vaccines, Consumer Healthcare
 
     
     
     

    Content :

    An integrated healthcare partner focused on patients' needs

    People are at the heart of everything we do at Sanofi. Through our vaccines, medicines and healthcare solutions, we help prevent and treat those in need.

    Since 1956, Sanofi has aligned itself with India's healthcare needs by building expertise, capability & capacity, through continued investments, strategic partnerships, and a shared commitment towards patients.

    Company statements

    May 23, 2016

    Company statement on the recall of Combiflam® batches

     

    Recent Media Releases

    July 19, 2016

    India’s infants to receive Shantha Biotechnics 'Made in India' ShanIPV™ for polio eradication

     

    Contact Us

    Sanofi

    Sanofi House,
    CTS No.117-B, L&T Business Park,
    Saki Vihar Road, Powai,
    Mumbai 400072

    Tel no. (022) 28032000
    Fax no.(022) 28032846

     

    Sanofi on YouTube

     

    Medical Information / Pharmacovigilance

    A key activity of Sanofi is to provide updated medical information on its products, to healthcare professionals, which is in compliance with Indian regulations. All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters.
    For medical information, contact:
    medinfo.india@sanofi.com / Tel no. (022) 28032000 , Extension 2063

    Sanofi also ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide, as pharmacovigilance remains a key activity in the assessment of the therapeutic value of products.
    For Reporting adverse events, contact:
    PV.india@sanofi.com / Tel no. (022) 28032000 , Extension 2055